|
KCTD9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.640200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.369000E-01 |
| Normal-vs-Stage2 |
2.944600E-01 |
| Normal-vs-Stage3 |
2.003000E-01 |
| Normal-vs-Stage4 |
9.635400E-01 |
| Stage1-vs-Stage2 |
5.969600E-01 |
| Stage1-vs-Stage3 |
5.665800E-01 |
| Stage1-vs-Stage4 |
5.292800E-01 |
| Stage2-vs-Stage3 |
9.774200E-01 |
| Stage2-vs-Stage4 |
4.315400E-01 |
| Stage3-vs-Stage4 |
3.813600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.236800E-01 |
| Normal-vs-AfricanAmerican |
2.386600E-01 |
| Normal-vs-Asian |
4.001200E-01 |
| Caucasian-vs-AfricanAmerican |
6.178600E-01 |
| Caucasian-vs-Asian |
2.978600E-01 |
| AfricanAmerican-vs-Asian |
1.887400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.007400E-01 |
| Normal-vs-Female |
1.535810E-01 |
| Male-vs-Female |
2.240200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.261400E-01 |
| Normal-vs-Extreme_Weight |
2.890000E-01 |
| Normal-vs-Obese |
2.255200E-01 |
| Normal-vs-Extreme_Obese |
5.861400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.576600E-01 |
| Normal_Weight-vs-Obese |
4.108200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.131400E-01 |
| Extreme_Weight-vs-Obese |
8.011400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.303000E-01 |
| Obese-vs-Extreme_Obese |
8.140200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.372000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.400400E-02 |
| Normal-vs-Age(61-80Yrs) |
9.738000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.913200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.800000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.165200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.584400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.460600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.072600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.899200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.154200E-01 |
| Normal-VS-Type2 PRCC |
4.757000E-01 |
| Normal-VS-KIRP CIMP |
1.644500E-02 |
| Normal-VS-Unclassified PRCC |
1.791990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.859200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.316200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.324600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.590240E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.188600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.341600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.979600E-01 |
| Normal-vs-N1 |
7.614200E-01 |
| Normal-vs-N2 |
1.519800E-01 |
| N0-vs-N1 |
4.885800E-01 |
| N0-vs-N2 |
3.817200E-01 |
| N1-vs-N2 |
1.489620E-01 |
|
|
